Search results for " graf"

showing 10 items of 456 documents

CT Angiography at 24 Months Demonstrates Durability of EVAR With the Use of Chimney Grafts for Pararenal Aortic Pathologies

2013

PURPOSE: To present the 24-month radiological follow-up data for patients with pararenal aortic pathologies treated with chimney and periscope grafts during endovascular repair. METHODS: Between January 2008 and December 2011, 124 high-risk patients with complex pararenal aortic pathologies were treated using the chimney technique at 2 European vascular and cardiovascular centers with advanced experience of the described technique. In particular, 50 patients were treated at Site 1 and 74 at Site 2. Forty (32.2%) patients (32 men; mean age 79.2±4.9 years) completed computed tomographic angiography follow-up at 24 months postoperatively. RESULTS: The overall technical success was 100%, and th…

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentAortic Diseases610 Medicine & healthEndovascular aneurysm repair2705 Cardiology and Cardiovascular MedicineAortic aneurysmAneurysmmedicine.arterymedicineHumans2741 Radiology Nuclear Medicine and ImagingRadiology Nuclear Medicine and imagingAorta AbdominalEmbolizationSuperior mesenteric arteryAgedendovascular aneurysm repair chimney graft periscope graft pararenal aortic pathologies aortic aneurysm para-anastomotic aneurysm ruptured aneurysm stent-graft balloon-expandable stent-graft computed tomographic angiography endoleak renal arteries superior mesenteric artery sac shrinkage sac expansionmedicine.diagnostic_test10042 Clinic for Diagnostic and Interventional Radiologybusiness.industryEndovascular ProceduresAngiographyPerioperativemedicine.diseaseBlood Vessel Prosthesis10020 Clinic for Cardiac Surgery2746 SurgerySurgeryCuffAngiographyFemaleStentsSurgeryRadiologyTomography X-Ray ComputedCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesJournal of Endovascular Therapy
researchProduct

Surgical conversion with graft salvage as a definitive treatment for persistent type II endoleak causing sacenlargement

2015

Objective The goal of this study was to present open surgical conversion with graft salvage or "semiconversion" as a definitive and safe treatment for untreatable and persistent type II endoleaks causing sac enlargement after endovascular aneurysm repair. Methods Between January 2001 and December 2014, 25 of 1623 endovascular aortic repair (EVAR) patients were selected as candidates for open semiconversion. The indication was persistent type II endoleak in 13 patients (12 of whom received previous attempts of embolization), type I and II endoleak in 2 patients, and sac growth without imaging evidence of endoleak in the other 10. After the infrarenal aorta was prepared (via a retroperitoneal…

Malemedicine.medical_specialtygraft salvageEndoleakmedicine.medical_treatmentSurgical conversionEndovascular aneurysm repairSettore MED/22 - Chirurgia VascolareBlood Vessel Prosthesis ImplantationAneurysmmedicineHumansEffective treatmentEmbolizationThrombusbusiness.industryMedicine (all)Patient SelectionEndovascular ProceduresPerioperativeCardiology and Cardiovascular Medicine; Surgerymedicine.diseaseConversion to Open SurgerySize increaseSurgeryEmergency conditionFemaleSurgerySurgical conversion; graft salvage; type II endoleakRadiologytype II endoleakCardiology and Cardiovascular MedicinebusinessConversion to Open Surgery; Endoleak; Endovascular Procedures; Female; Humans; Male; Patient Selection; Blood Vessel Prosthesis Implantation; Cardiology and Cardiovascular Medicine; Surgery; Medicine (all)
researchProduct

How should I treat concomitant post-endarterectomy carotid pseudoaneurysm and contralateral symptomatic stenosis?

2010

Background A 74-year-old male patient complaining of crescendo TIAs, hypertension and hyperlipidaemia. Investigation Duplex ultrasound scan MR angiography. Diagnosis Pseudoaneurysm stemming from the ICA. Treatment An open or endovascular procedure for the right pECCA repair, or a left CEA or CAS.

Malemedicine.medical_specialtymedicine.medical_treatmentEndarterectomycarotid artery stenosistent graftSettore MED/22 - Chirurgia VascolareCentral nervous system diseasePseudoaneurysmmedicineHumansCarotid Stenosiscardiovascular diseasesCarotid PseudoaneurysmEndarterectomyAgedVascular diseasebusiness.industrymedicine.diseasecarotid pseudoaneurysmSurgeryStenosisMale patientConcomitantcardiovascular systemstentRadiologyCardiology and Cardiovascular MedicinebusinessCarotid Artery InjuriesCarotid Artery InternalEuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
researchProduct

CEMENTLESS ACETABULAR RECONSTRUCTION AND STRUCTURAL BONE-GRAFTING IN DYSPLASTIC HIPS

2006

BACKGROUND: Studies of acetabular reconstruction with use of cement and bulk bone graft have demonstrated increasing rates of cup failure in patients with dysplastic hips seven years after total hip arthroplasty. Comparable data on the long-term results of bulk bone-grafting done in conjunction with cementless implants are limited. The aim of this study was to review the clinical and radiographic results of autologous bulk bone-grafting in conjunction with a cementless cup. METHODS: From 1987 to 1992, forty-seven patients (forty women and seven men, with an average age of 50.4 years) who had developmental dysplasia of the hip underwent fifty-six total hip arthroplasties and received a struc…

Malemusculoskeletal diseasesmedicine.medical_specialtyRadiographymedicine.medical_treatmentBone graftingHumansMedicineOrthopedic ProceduresOrthopedics and Sports MedicineProspective StudiesSurvival rateBone TransplantationHipbusiness.industryAcetabular reconstructionAcetabulumGeneral MedicineMiddle AgedAcetabulumSurgerysurgical procedures operativemedicine.anatomical_structureHip boneOrthopedic surgeryFemaleSurgeryHip ProsthesisImplantbusinessThe Journal of Bone and Joint Surgery-American Volume
researchProduct

NANOPARTICLES BASED ON NOVEL AMPHIPHILIC POLYASPARTAMIDE COPOLYMERS

2010

In this article, the synthesis of two amphiphilic polyaspartamide copolymers, useful to obtain polymeric nanoparticles without using surfactants or stabilizing agents, is described. These copolymers were obtained starting from α,β-poly-(N-2-hydroxyethyl)-dl-aspartamide (PHEA) by following a novel synthetic strategy. In particular, PHEA and its pegylated derivative (PHEA-PEG2000) were functionalized with poly(lactic acid) (PLA) through 1,1′-carbonyldiimidazole (CDI) activation to obtain PHEA–PLA and PHEA-PEG2000–PLA graft copolymers, respectively. These copolymers were properly purified and characterized by 1H-NMR, FT-IR, and Size Exclusion Chromatography (SEC) analyses, which confirmed that…

Materials scienceALPHABETA-poly-(N-2-hydroxyethyl)-DL-aspartamide (PHEA) poly(lactic acid) (PLA) poly(ethylene glycol) (PEG) graft copolymers nanoparticlesSize-exclusion chromatographytechnology industry and agricultureNanoparticleBioengineeringGeneral Chemistrymacromolecular substancesCondensed Matter PhysicsAtomic and Molecular Physics and Opticschemistry.chemical_compoundX-ray photoelectron spectroscopychemistrystomatognathic systemSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoModeling and SimulationAmphiphilePolymer chemistryPEG ratioCopolymerZeta potentialGeneral Materials ScienceDerivatization
researchProduct

Densely PEGylated polybenzofulvene brushes for potential applications in drug encapsulation

2018

The technique of grafting side chains onto a linear polymeric backbone is commonly used to confer to the new polymeric material with desired properties, such as tunable solubility, ionic charge, biocompatibility, or specific interactions with biological systems. In this paper, two new polybenzofulvene backbones were assembled by spontaneous polymerization of the appropriate benzofulvene monomers (4,6-PO-BF3k and 4&rsquo

Materials scienceBiocompatibilityDrug delivery systemlcsh:RS1-441Pharmaceutical ScienceNanotechnology02 engineering and technology010402 general chemistry01 natural sciencesArticlelcsh:Pharmacy and materia medicachemistry.chemical_compounddrug delivery systemsAffinity polymerization; Drug delivery systems; Grafting onto; Nanocarrier; PEGylation; Polybenzofulvene; Spontaneous polymerization;grafting ontoSide chainaffinity polymerizationPEGylation021001 nanoscience & nanotechnologyGrafting0104 chemical sciencesMonomerchemistryPolymerizationspontaneous polymerizationPEGylationnanocarrierNanocarriersPolybenzofulvene0210 nano-technologypolybenzofulvene;Ethylene glycol
researchProduct

ePTFE ‐based biomedical devices: An overview of surgical efficiency

2021

International audience; Polytetrafluoroethylene (PTFE) is a ubiquitous material used for implants and medical devices in general because of its high biocompatibility and inertness: blood vessel, heart, table jawbone, nose, eyes, or abdominal wall can benefit from its properties in case of disease or injury. Its expanded version, ePTFE is an improved version of PTFE with better mechanical properties, which extends its medical applications. A material as frequently used as ePTFE with these exceptional properties deserves a review of its main uses, developments, and possibility of improvements. In this systematic review, we examined clinical trials related to ePTFE-based medical devices from t…

Materials scienceBiocompatibilityimplantmedicine.medical_treatmentmembrane barrierBiomedical EngineeringBypass grafts030204 cardiovascular system & hematologyBiomaterials03 medical and health scienceschemistry.chemical_compound0302 clinical medicineRenal DialysismedicineGuided bone and tissue regeneration[SPI.NANO]Engineering Sciences [physics]/Micro and nanotechnologies/MicroelectronicsePTFEPolytetrafluoroethyleneclinical trialsPolytetrafluoroethylenevascular graftStent030206 dentistryBlood Vessel Prosthesis3. Good health[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologychemistryStentsstentHeart repairImplantVascular graftBiomedical engineering
researchProduct

Hepatocyte-targeted fluorescent nanoparticles based on a polyaspartamide for potential theranostic applications

2015

Abstract Here, the synthesis of a galactosylated amphiphilic copolymer bearing rhodamine (RhB) moieties and its use for the preparation of polymeric fluorescent nanoparticles for potential applications in therapy and diagnosis are described. To do this, firstly, a fluorescent derivative of α,β-poly( N -2-hydroxyethyl)- d , l -aspartamide (PHEA) was synthesized by chemical reaction with RhB, and with polylactic acid (PLA), to obtain PHEA-RhB-PLA. Then, the derivatization of PHEA-RhB-PLA with GAL-PEG-NH 2 allows obtaining PHEA-RhB-PLA-PEG-GAL copolymer, with derivatization degrees in -PLA and -PEG-GAL equal to 1.9 mol% and 4.5 mol%, respectively. Starting from this copolymer, liver-targeted f…

Materials sciencePolymers and PlasticsOrganic Chemistrytechnology industry and agricultureNanoparticlemacromolecular substancesCombinatorial chemistryFluorescenceRhodaminechemistry.chemical_compoundPolylactic acidchemistrySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoPolymer chemistryMaterials ChemistryZeta potentialCopolymerAsialoglycoprotein receptorActive targeting alphabeta-Poly-(N-2-hydroxyethyl)-DL-aspartamide (PHEA) Fluorescence imaging Graft copolymers NanoparticlesDerivatization
researchProduct

Nonthrombogenic, Biodegradable Elastomeric Polyurethanes with Variable Sulfobetaine Content

2014

For applications where degradable polymers are likely to have extended blood contact, it is often important for these materials to exhibit high levels of thromboresistance. This can be achieved with surface modification approaches, but such modifications may be transient with degradation. Alternatively, polymer design can be altered such that the bulk polymer is thromboresistant and this is maintained with degradation. Toward this end a series of biodegradable, elastic polyurethanes (PESBUUs) containing different zwitterionic sulfobetaine (SB) content were synthesized from a polycaprolactone-diol (PCL-diol):SB-diol mixture (100:0, 75:25, 50:50, 25:75 and 0:100) reacted with diisocyanatobuta…

Materials sciencePolyurethanesThrombogenicityBiocompatible MaterialsElastomerFibrinolytic AgentsHardnessTensile StrengthUltimate tensile strengthPolymer chemistryAbsorbable ImplantsMaterials TestingAnimalsGeneral Materials ScienceBlood Coagulationchemistry.chemical_classificationbiodegradable polyurethane sulfobetaine cardiovascular thromboresistance vascular graft zwitterionPolymerBiodegradationElectrospinningBetainechemistryChemical engineeringSurface modificationDegradation (geology)Cattle
researchProduct

Endothelialization of chitosan porous conduits via immobilization of a recombinant fibronectin fragment (rhFNIII7–10)

2013

Abstract The present study aimed to develop a pre-endothelialized chitosan (CH) porous hollowed scaffold for application in spinal cord regenerative therapies. CH conduits with different degrees of acetylation (DA; 4% and 15%) were prepared, characterized (microstructure, porosity and water uptake) and functionalized with a recombinant fragment of human fibronectin (rhFNIII 7–10 ). Immobilized rhFNIII 7–10 was characterized in terms of amount ( 125 I-radiolabelling), exposure of cell-binding domains (immunofluorescence) and ability to mediate endothelial cell (EC) adhesion and cytoskeletal rearrangement. Functionalized conduits revealed a linear increase in immobilized rhFNIII 7–10 with rhF…

Materials scienceProtein radiolabellingBiomedical EngineeringNeovascularization PhysiologicSpinal cord injuryBiochemistrylaw.inventionBiomaterialsChitosanchemistry.chemical_compoundTissue engineeringlawSpectroscopy Fourier Transform InfraredPolymer chemistryHumansSurface graftingCytoskeletonMolecular BiologyFluorescent DyesChitosanTissue ScaffoldsbiologyThree-dimensional scaffoldsEndothelial CellsDNAGeneral MedicineAdhesionGraftingRecombinant ProteinsFibronectinsProtein Structure TertiaryFibronectinEndothelial stem cellImmobilized ProteinschemistryProtein conformationMicroscopy Electron Scanningbiology.proteinRecombinant DNABiophysicsAdsorptionPorosityBiotechnology
researchProduct